The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines

Ivana Stanic, Annalisa Facchini, Rosa Maria Borzì, Claudio Stefanelli, Flavio Flamigni

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We have been investigating the effects of natural polyamines and polyamine analogues on the survival and apoptosis of chondrocytes, which are cells critical for cartilage integrity. Treatment of human C-28/I2 chondrocytes with N1,N11-diethylnorspermine (DENSPM), a polyamine analogue with clinical relevance as anexperimental anticancer agent, rapidly induced spermidine/spermine N1-acetyltransferase (SSAT) and spermine oxidase (SMO), key enzymesofpolyamine catabolism and down-regulated ornithine decarboxylase, thefirst enzyme of polyamine biosynthesis, thus depleting all main polyamines within 24 h. The treatment with DENSPM did not provoke cell death and caspase activation when given alone for 24 h, but caused a caspase-3 and -9 dependent apoptosis in chondrocytes further exposed to cycloheximide (CHX). In other cellular models, enhanced polyamine catabolism or polyamine depletion has been implicated as mechanisms involvedinDENSPM-related apoptosis. However, the simultaneous additionof DENSPM and CHX rapidly increased caspase activity in C-28/I2 cells in the absence of SSAT and SMO induction or significant reduction of polyamine levels. Moreover, caspase activation induced by DENSPM plus CHX was not prevented by a N1-acetylpolyamine oxidase (PAO)/SMO inhibitor, and depletion of all polyamines obtained by specific inhibitors of polyamine biosynthesis did not reproduce DENSPM effects in the presence of CHX. DENSPM/CHX-induced apoptosis was associated with changes in the amount or activation of signalling kinases, Akt and MAPKs, and increased uptake of DENSPM. In conclusion, the results suggest that DENSPM can favour apoptosis in chondrocytes independently of its effects on polyamine metabolism and levels.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalJournal of Cellular Physiology
Volume219
Issue number1
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Polyamines
Chondrocytes
Metabolism
Apoptosis
Cycloheximide
Caspases
Acetyltransferases
Spermidine
Spermine
Chemical activation
Biosynthesis
Ornithine Decarboxylase
Caspase 9
Mitogen-Activated Protein Kinase Kinases
Cartilage
Cell death
Caspase 3
Antineoplastic Agents
Oxidoreductases
Cell Death

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines. / Stanic, Ivana; Facchini, Annalisa; Borzì, Rosa Maria; Stefanelli, Claudio; Flamigni, Flavio.

In: Journal of Cellular Physiology, Vol. 219, No. 1, 04.2009, p. 109-116.

Research output: Contribution to journalArticle

@article{10d1ae8cd7554137bfb9f3ba4a68ef6f,
title = "The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines",
abstract = "We have been investigating the effects of natural polyamines and polyamine analogues on the survival and apoptosis of chondrocytes, which are cells critical for cartilage integrity. Treatment of human C-28/I2 chondrocytes with N1,N11-diethylnorspermine (DENSPM), a polyamine analogue with clinical relevance as anexperimental anticancer agent, rapidly induced spermidine/spermine N1-acetyltransferase (SSAT) and spermine oxidase (SMO), key enzymesofpolyamine catabolism and down-regulated ornithine decarboxylase, thefirst enzyme of polyamine biosynthesis, thus depleting all main polyamines within 24 h. The treatment with DENSPM did not provoke cell death and caspase activation when given alone for 24 h, but caused a caspase-3 and -9 dependent apoptosis in chondrocytes further exposed to cycloheximide (CHX). In other cellular models, enhanced polyamine catabolism or polyamine depletion has been implicated as mechanisms involvedinDENSPM-related apoptosis. However, the simultaneous additionof DENSPM and CHX rapidly increased caspase activity in C-28/I2 cells in the absence of SSAT and SMO induction or significant reduction of polyamine levels. Moreover, caspase activation induced by DENSPM plus CHX was not prevented by a N1-acetylpolyamine oxidase (PAO)/SMO inhibitor, and depletion of all polyamines obtained by specific inhibitors of polyamine biosynthesis did not reproduce DENSPM effects in the presence of CHX. DENSPM/CHX-induced apoptosis was associated with changes in the amount or activation of signalling kinases, Akt and MAPKs, and increased uptake of DENSPM. In conclusion, the results suggest that DENSPM can favour apoptosis in chondrocytes independently of its effects on polyamine metabolism and levels.",
author = "Ivana Stanic and Annalisa Facchini and Borz{\`i}, {Rosa Maria} and Claudio Stefanelli and Flavio Flamigni",
year = "2009",
month = "4",
doi = "10.1002/jcp.21655",
language = "English",
volume = "219",
pages = "109--116",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines

AU - Stanic, Ivana

AU - Facchini, Annalisa

AU - Borzì, Rosa Maria

AU - Stefanelli, Claudio

AU - Flamigni, Flavio

PY - 2009/4

Y1 - 2009/4

N2 - We have been investigating the effects of natural polyamines and polyamine analogues on the survival and apoptosis of chondrocytes, which are cells critical for cartilage integrity. Treatment of human C-28/I2 chondrocytes with N1,N11-diethylnorspermine (DENSPM), a polyamine analogue with clinical relevance as anexperimental anticancer agent, rapidly induced spermidine/spermine N1-acetyltransferase (SSAT) and spermine oxidase (SMO), key enzymesofpolyamine catabolism and down-regulated ornithine decarboxylase, thefirst enzyme of polyamine biosynthesis, thus depleting all main polyamines within 24 h. The treatment with DENSPM did not provoke cell death and caspase activation when given alone for 24 h, but caused a caspase-3 and -9 dependent apoptosis in chondrocytes further exposed to cycloheximide (CHX). In other cellular models, enhanced polyamine catabolism or polyamine depletion has been implicated as mechanisms involvedinDENSPM-related apoptosis. However, the simultaneous additionof DENSPM and CHX rapidly increased caspase activity in C-28/I2 cells in the absence of SSAT and SMO induction or significant reduction of polyamine levels. Moreover, caspase activation induced by DENSPM plus CHX was not prevented by a N1-acetylpolyamine oxidase (PAO)/SMO inhibitor, and depletion of all polyamines obtained by specific inhibitors of polyamine biosynthesis did not reproduce DENSPM effects in the presence of CHX. DENSPM/CHX-induced apoptosis was associated with changes in the amount or activation of signalling kinases, Akt and MAPKs, and increased uptake of DENSPM. In conclusion, the results suggest that DENSPM can favour apoptosis in chondrocytes independently of its effects on polyamine metabolism and levels.

AB - We have been investigating the effects of natural polyamines and polyamine analogues on the survival and apoptosis of chondrocytes, which are cells critical for cartilage integrity. Treatment of human C-28/I2 chondrocytes with N1,N11-diethylnorspermine (DENSPM), a polyamine analogue with clinical relevance as anexperimental anticancer agent, rapidly induced spermidine/spermine N1-acetyltransferase (SSAT) and spermine oxidase (SMO), key enzymesofpolyamine catabolism and down-regulated ornithine decarboxylase, thefirst enzyme of polyamine biosynthesis, thus depleting all main polyamines within 24 h. The treatment with DENSPM did not provoke cell death and caspase activation when given alone for 24 h, but caused a caspase-3 and -9 dependent apoptosis in chondrocytes further exposed to cycloheximide (CHX). In other cellular models, enhanced polyamine catabolism or polyamine depletion has been implicated as mechanisms involvedinDENSPM-related apoptosis. However, the simultaneous additionof DENSPM and CHX rapidly increased caspase activity in C-28/I2 cells in the absence of SSAT and SMO induction or significant reduction of polyamine levels. Moreover, caspase activation induced by DENSPM plus CHX was not prevented by a N1-acetylpolyamine oxidase (PAO)/SMO inhibitor, and depletion of all polyamines obtained by specific inhibitors of polyamine biosynthesis did not reproduce DENSPM effects in the presence of CHX. DENSPM/CHX-induced apoptosis was associated with changes in the amount or activation of signalling kinases, Akt and MAPKs, and increased uptake of DENSPM. In conclusion, the results suggest that DENSPM can favour apoptosis in chondrocytes independently of its effects on polyamine metabolism and levels.

UR - http://www.scopus.com/inward/record.url?scp=60849133029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60849133029&partnerID=8YFLogxK

U2 - 10.1002/jcp.21655

DO - 10.1002/jcp.21655

M3 - Article

VL - 219

SP - 109

EP - 116

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 1

ER -